Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other Accumulated Expenses (2018 - 2025)

Historic Other Accumulated Expenses for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $15.8 million.

  • TransMedics' Other Accumulated Expenses rose 835.67% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 835.67%. This contributed to the annual value of $9.6 million for FY2024, which is 1808.14% down from last year.
  • As of Q3 2025, TransMedics' Other Accumulated Expenses stood at $15.8 million, which was up 835.67% from $12.2 million recorded in Q2 2025.
  • TransMedics' 5-year Other Accumulated Expenses high stood at $15.8 million for Q3 2025, and its period low was $1.5 million during Q2 2021.
  • Its 5-year average for Other Accumulated Expenses is $7.6 million, with a median of $5.3 million in 2023.
  • Per our database at Business Quant, TransMedics' Other Accumulated Expenses plummeted by 4134.66% in 2023 and then surged by 39145.65% in 2024.
  • Over the past 5 years, TransMedics' Other Accumulated Expenses (Quarter) stood at $4.6 million in 2021, then dropped by 5.58% to $4.4 million in 2022, then skyrocketed by 169.56% to $11.8 million in 2023, then dropped by 18.08% to $9.6 million in 2024, then skyrocketed by 64.35% to $15.8 million in 2025.
  • Its last three reported values are $15.8 million in Q3 2025, $12.2 million for Q2 2025, and $13.8 million during Q1 2025.